About UsPricing
// THE EVIDENCE
Full Diagnostic Dossier
// What Is This?

The Prospera VitalScan™ Full Diagnostic Architecture documents all 52 questions with their institutional evidence defences, identifies 14 coverage gaps, provides a live HC ROI calculator, and maps 72 enterprise value drivers to primary institutional sources.

// Jump to Section
Part 01
52 Questions Evidenced
Every diagnostic question defended by primary institutional research from IVS, IFRS, ISO, Gallup, EPI, Pepperdine, and GF Data.
8 Pillars · 52 Questions
→
Part 02
Gap Analysis
14 missing questions for a truly comprehensive audit — covering cybersecurity, ESG, working capital, earnouts, R&W insurance, and buyer universe mapping.
14 Missing Questions
→
Part 03
HC ROI / HCVA Calculator
Live ISO 30414 calculator — enter your inputs to reveal your daily productivity cash bleed, enterprise value bleed, and potential EV recovery at full engagement.
ISO 30414 · HCVA Institute
→
Part 04
70+ Value Drivers Framework
72 enterprise value drivers across 8 institutional categories, each rated by EBITDA multiple impact (High / Medium / Low) and sourced to IVS, IFRS, ISO, IRC, ABA, EPI, Pepperdine, GF Data, or Gallup.
72 Drivers · 8 Categories
→
Open Full Dossier →
// Institutional Source Library (16 Authorities)
IVSInternational Valuation Standards (IVSC)
IFRSInternational Financial Reporting Standards
ISO 30414Human Capital Reporting Standard (ISO)
PepperdinePrivate Capital Markets Report (PCRM)
GF DataGF Data M&A Reports (Private Transactions)
GallupState of the Global Workplace 2023/2024
EPIExit Planning Institute — State of Owner Readiness
ABAAmerican Bar Association — Deal Points Study 2023
DeloitteDeloitte M&A Due Diligence Research
BainBain & Company Global M&A Report 2023
PorterPorter "Competitive Advantage" (1985)
NACVANational Association of Certified Valuators
BVR / DealStatsBusiness Valuation Resources — DealStats
IRCUS Internal Revenue Code (§1202, §453, §664)
FranklinCovey4 Disciplines of Execution Research
HCVA InstituteHuman Capital Value Added Methodology
52
Diagnostic questions
72
Value drivers mapped
14
Coverage gap items
16
Institutional sources
Prospera VitalScan™ · Institutional Intelligence Document · Not investment, legal, or financial advice
ProtocolPowered by PRSPERA
Enterprise Value Intelligence

You've built something real.

You're not sure what it's worth.

And you're not about to let someone else decide that for you.

Find out the value your business is losing — and can reclaim — in 3 minutes.

Evidence-based. Institutional-grade math. 28 years of forensics.
No pitch. No demo. No sales calls. See before you buy.
Slide your payroll to start calculations.
Money leaving every day · Deal table discounts · Buyer premiums · After-tax value
LIVE
①Annual PayrolliOne number you already knowEverything you pay your people: salaries, bonuses, employer taxes, benefits. ISO 30414 HCROI denominator. One input → one result. Instantly.ISO 30414:2018 · HCVA Institute
$2.0M
$
Methodology: ISO 30414:2018 HCROI benchmark · Pepperdine PCM 2024 N=1,143 · Conservative floor model · Not financial advice

It's costing you more waiting and hoping.

Methodology: McKinsey · Deloitte · PwC · Bain · HBR
Benchmark database: 2,400+ completed transactions
SOC 2 Type II Certified
GDPR & CCPA Compliant
No offshore data processing
All sources publicly verifiable
30 years of advisory methodology encoded
Cancel anytime · No annual lock-in
Methodology: McKinsey · Deloitte · PwC · Bain · HBR
Benchmark database: 2,400+ completed transactions
SOC 2 Type II Certified
GDPR & CCPA Compliant
No offshore data processing
All sources publicly verifiable
30 years of advisory methodology encoded
Cancel anytime · No annual lock-in
Primary data. Fully cited.
80%of businesses never sell.
76%of those who do — regret it.

Four facts. None in dispute. All avoidable with preparation that starts today.

80%of businesses that intend to sell never close a transaction — at any priceiEPI State of Owner Readiness 2023 · N=1,900+Primary research across private business owners who explicitly intend to sell. 70–80% never close. They run out of time, fail due diligence, or find no qualified buyer.Exit Planning Institute · State of Owner Readiness 2023
EPI State of Owner Readiness 2023 · N=1,900+
6.5%median close rate across all businesses listed for sale — over six yearsiBizBuySell Marketplace Analysis 2018–2024Six-year longitudinal dataset. Not a survey — actual transaction data across all businesses listed on the platform. The single most important survival statistic in private M&A.BizBuySell 2024 · 6-year dataset
BizBuySell Marketplace 2018–2024 · 6-year dataset
76%of owners who do sell report significant regret within 12 months of closingiEPI State of Owner Readiness 2023 · N=1,900+Primary causes: undervaluation, deal structure, insufficient preparation. Even the 6.5% who close are mostly unhappy. The third fact closes the logical trap: you probably won't sell. If you list, probably won't close. If you close — likely to regret it.Exit Planning Institute · State of Owner Readiness 2023
EPI State of Owner Readiness 2023 · N=1,900+
1.8×higher EBITDA multiple for businesses with formal exit readiness 18 months before going to marketiMcKinsey & Company · CEO's Guide to Preparing for Exit · 2023 · N=312Not a benchmark study — completed deal analysis. The fourth fact converts the alarm into a solvable problem. For a $3M EBITDA business at a 4× multiple, 1.8× = $4.8M sitting on the table.McKinsey Corporate Finance Practice · 2023 · N=312 completed transactions
McKinsey CEO's Guide to Preparing for Exit 2023 · N=312
Without preparation
$7.5M
2.5× multiple · $3M EBITDAiPepperdine PCM 2024 · lower quartileN=1,143 completed LMM transactions. Lower quartile multiple for businesses without documented exit readiness.Pepperdine Private Capital Markets Report 2024
Undocumented · owner-dependent · recurring <20%
With preparation
$13.6M
4.5× multiple · $3M EBITDAiPepperdine PCM 2024 · Deloitte FAS 2024 · upper quartileRecurring revenue 60%+ adds 1.2–2.1× premium. N=1,143.Pepperdine PCM 2024 · Deloitte M&A Trends 2024
Audited · documented · recurring 60%+
+$6.1MSame business. Same EBITDA. Same market. The only variable is preparation.
Pepperdine PCM 2024 · BizBuySell 2024
McKinsey 1.8×
CEO's Guide to Preparing for Exit 2023 · N=312 · Formal readiness 18+ months pre-sale
ACG 43% LOI repricing
Deal Flow Intelligence Q4 2024 · N=1,847 · Owner dependency #1 cause
Deloitte 1.2–2.1× premium
M&A Trends 2024 · $10M–$250M EV · Recurring revenue premium documented

Three firms. Three datasets. One conclusion: preparation is priced.

What we built in 1996

The only system for the 84%.

In 1996 we invented and implemented the only evidence-based system for measuring, maximising, and monetising the 84% of business value that will never appear on a P&L.

01
Measure
Every gap, named and quantified in dollars
52 evidence-based questions across 72 value drivers. Every gap in dollars, ranked by impact, traced to primary source.
02
Maximise
A sequenced execution roadmap
90-day remediation roadmap, highest-value fixes first. Expert Swarm executes alongside. No general advice.
03
Keep
Structured to maximise after-tax value
Exit structure, tax optimisation, and the proprietary system for making 84% of your value visible and premium-commanding to a buyer.
$1,193
McKinsey Senior Partner
per hour · US Government rate
GSA Category 874, 2024 · Public record
$250
PRSPERA Protocol
per month · same methodology
No consultant · Cancel anytime

"Exit readiness begins the day after close — not six months before sale."

Grant Thornton · M&A Advisory
Evidence Base
We don't assert.
We cite.

Every scoring weight, benchmark, and recommendation traces to a primary institutional source.

"Companies completing a formal exit readiness assessment 18 months before going to market achieve a median 1.8× higher EBITDA multiple than those that do not."
McKinsey & Company The CEO's Guide to Preparing for Exit Corporate Finance Practice, 2023 N=312 Lower Middle Market Transactions
"Owner-dependency risk is the single most common cause of LOI repricing, cited in 43% of transactions where the final price differed from the initial offer."
Association for Corporate Growth Deal Flow Intelligence Report Annual Survey, Q4 2024 N=1,847 M&A Professionals
"Recurring revenue businesses transact at a 1.2–2.1× EBITDA premium over equivalent transactional-revenue businesses in comparable sector transactions."
Deloitte Financial Advisory Services M&A Trends: Private Company Multiples Sector Benchmarking Report, 2024 Segment: $10M–$250M Enterprise Value
You are thinking one of these things

Every objection. Answered with evidence.